Published Reported
Testosterone on the rise
Optimal testosterone levels may lower the risk of obesity, type 2 diabetes and cardiovascular disease, and low testosterone may be a biological accelerant of aging and chronic disease.
In The News
Published Reported
Optimal testosterone levels may lower the risk of obesity, type 2 diabetes and cardiovascular disease, and low testosterone may be a biological accelerant of aging and chronic disease.
Published Reported
Guidelines list untreated prostate or breast cancer and severe heart failure as contraindications, a hematocrit above about 48 to 50% is a relative reason to avoid or delay therapy, and testosterone is not...
Published Reported
Testosterone-related erythrocytosis is usually preventable by changing formulation or dose, and phlebotomy is indicated for hematocrit of 54% to 55% or higher.
Published Reported
Testosterone therapy was not associated with an increased risk of major adverse cardiovascular events, but pulmonary embolism and atrial fibrillation were more frequent in the treatment group.
Shared decision making
Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.
Create a free account or log in to save and bookmark articles.